Vir Biotechnology, Inc.

NASDAQ:VIR

Biotechnology

Healthcare
$9.15 -2.63%

-$0.25 today

Market cap
$1.57B
Beta
1.64
P/E (TTM)
-3.0
EPS (TTM)
-$3.00
52W Low $4.16High $11.66

Volume 2.15M

Average 1.76M

VIR Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Vir Biotechnology, Inc.NASDAQ: VIR

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 9793.1%

Gross margin was 9793.1% in Q1 FY2026, up 13572.2 pp from a year earlier. On a trailing-twelve-month basis it was 275.2%, up 2604.6 pp year over year. Over 3 fiscal years it widened by 21.4 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
9793.1%+9121.0 pp QoQ
Last fiscal yearDec 2025
82.9%+628.0 pp YoY
LTMMar 2026
275.2%+2604.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+13572.2 pp——
1 year+628.0 pp——
3 years+21.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
82.9%
Year-over-year change
+628.0pp

Gross Margin vs competitors

How VIR compares with its peers on the latest reported figures

  • VIR's LTM Mar 2026 gross margin of 275.2% is the highest of the 9 companies compared; the peer median is 74.0%.
  • Its year-over-year change of +2604.6 pp is the highest of 9, against a peer median of -2.3 pp.
  • Over three fiscal years its change of +21.4 pp compares with a peer median of -2.6 pp.
VIR Competitors Peer median
Gross Margin for VIR and competitors
Company Period LTM level YoY 3-year change
VIRVir Biotechnology, Inc.LTM Mar 2026275.2% +2604.6 pp+21.4 pp
ABUSArbutus Biopharma CorporationLTM Mar 2026100.0% +277.5 pp-2.6 pp
ENTAEnanta Pharmaceuticals, Inc.LTM Mar 202698.3% -1.7 pp-7.0 pp
NVAXNovavax, Inc.LTM Mar 202684.6% -2.8 pp+50.1 pp
ASMBAssembly Biosciences, Inc.LTM Mar 202677.2% +110.0 pp—
BNTXBioNTech SELTM Jun 202670.8% -8.9 pp-5.1 pp
VALNValneva SELTM Mar 202629.5% -17.1 pp+28.5 pp
MRNAModerna, Inc.LTM Sep 202628.0% +16.1 pp-16.0 pp
BCRXBioCryst Pharmaceuticals, Inc.LTM Jun 202623.5% -73.5 pp+0.3 pp
AVIRAtea Pharmaceuticals, Inc.FY2025— ——
Peer median (excluding VIR) 74.0%-2.3 pp-2.6 pp

Competitors are the stored peer set for VIR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.1B1.62B86.18M74.21M68.56M
Cost of Revenue513.87M620.97M572.83M478.65M11.71M
Gross Profit581.54M994.83M(486.65M)(404.44M)56.85M
Gross Margin53.1%61.6%-564.7%-545.0%82.9%
Research & Development448.01M474.65M579.72M506.5M432.8M
Selling, General & Admin000092.07M
Operating Expenses160.79M161.76M197.66M182.73M524.87M
Depreciation & Amortization5.81M6.78M19.45M14.56M11.68M
EBITDA555.61M761.06M(641.64M)(508.91M)(426.09M)
EBITDA Margin50.7%47.1%-744.5%-685.8%-621.5%
Operating Income420.75M833.07M(684.31M)(587.17M)(468.02M)
Operating Margin38.4%51.6%-794.0%-791.3%-682.7%
Interest Income439K28.09M86.99M71.81M40.24M
Interest Expense00000
Other Income / Expenses129.05M(78.79M)56.11M64.06M30.25M
Income Before Tax549.8M754.28M(628.19M)(523.11M)(437.77M)
Pre-Tax Margin50.2%46.7%-728.9%-704.9%-638.6%
Income Tax Expense21.22M238.44M(13.08M)(1.15M)217K
Net Income528.58M515.84M(615.06M)(521.96M)(437.99M)
Net Margin48.3%31.9%-713.7%-703.4%-638.9%
EPS (Basic)4.073.89(4.59)(3.83)(3.16)
EPS (Diluted)3.963.83(4.59)(3.83)(3.16)
Weighted Avg Shares129.88M132.61M134.13M136.25M138.52M
Weighted Avg Shares (Diluted)133.44M134.81M134.13M136.25M138.52M

Vir Biotechnology, Inc.

NASDAQ:VIR

Intrinsic Alpha fair value

Locked

Current Price

$9.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.